Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /SATKARTAR
chevron_leftBack
Sat Kartar Life Ltd. logo

Sat Kartar Life Ltd.

SATKARTAR
• NSE: SATKARTAR • Delayed
200.10INR 0%
2.10 USD
As of 6 June 2026, Sat Kartar Life Ltd. has a market cap of $32.9M USD, ranking #33612 globally and #2233 in India. It ranks #3039 in the Healthcare sector, and #178 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
33612
Country Rank
2233
Sector Rank
3039
Industry Rank
178
Key Stats
Market Cap
$32.9MUSD
3.15B INR
Enterprise Value
$30.2MUSD
2.88B INR
PB Ratio
5.4
Company Profile
Country (HQ)
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ved Prakash open_in_new
Employees
922
Founded
2012
Website
satkartar.in open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 1.8% 25% 43% 8.7% 37%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
SATKARTAR
Sat Kartar Shopping Ltd
ISIN: INE0NB801022
Shares Out.:
15.745M1
TV:
NSE: SATKARTAR
SA:
NSE: SATKARTAR
YF:
SATKARTAR.NS
GF:
NSE: SATKARTAR
BA:
SATKARTAR
MS:
XNSE: SATKARTAR
200.10 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Sat Kartar Life Ltd.

Sat Kartar Life Limited, an ayurvedic healthcare company, provides ayurvedic products in India. The company offers ayurvedic products, vitamins, supplements, and herbal products for various health conditions, including piles, diabetes, sexual health, stamina booster, immunity booster, infertility, joint pain, hair care, addiction care, and respiratory health solutions. It also sells its products through online. The company was formerly known as Sat Kartar Shopping Limited and change its name to Sat Kartar Life Limited in February 2026. The company was incorporated in 2012 and is based in New Delhi, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
PE
Cipla Ltd.
CIPLA
$11.12B
1.06T INR
34K%
23.4
Lupin Ltd.
LUPIN
$11.0B
1.05T INR
33K%
22.7
Aurobindo Pharma Ltd.
AUROPHARMA
$8.43B
807.02B INR
26K%
23.1
Cohance Lifesciences Ltd.
SUVENPHAR
$1.87B
178.87B INR
6K%
199.0
Granules India Ltd.
GRANULES
$1.83B
174.85B INR
5K%
32.1
Viyash Scientific Ltd.
SEQUENT
$944.92M
90.48B INR
3K%
92.7
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
Teva Pharmaceutical Industries Ltd.
TEVA
$37.66B
108.92B ILS
114K%
24.2
Revolution Medicines, Inc.
RVMD
$29.56B
90K%
-
Zhejiang NHU Company Ltd.
002001
$15.86B
107.34B CNY
48K%
16.0
Haisco Pharmaceutical Group Co., Ltd.
002653
$9.1B
61.6B CNY
28K%
80.6
ABIVAX Société Anonyme
ABVX
$8.79B
7.57B EUR
27K%
-
Dong-E-E-Jiao Co., Ltd.
000423
$5.22B
35.33B CNY
16K%
20.0
chevron_leftBack